1 completed, 1 unknown. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Madaus Inc: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Therapeutic Effects of Silymarin in Patients With B-thalassemia Major Silymarin (LEGALON), Placebo - Beta-thalassemia Major, Iron Overload | Phase 2 / Phase 3 | Unknown | Isfahan University of Medical Sciences | 140 | 2009-03-01 | 2009-10-21 |
| Phase II Trial of Silymarin for Non-Cirrhotic Patients With Non-Alcoholic Steatohepatitis Placebo, Silymarin 700 mg, Silymarin 420 mg - Non-alcoholic Steatohepatitis | Phase 2 | Completed | Madaus Inc | 78 | 2008-04-01 | 2019-07-17 |
Iron Overload (1) · Non-alcoholic Fatty Liver Disease (1) · beta-Thalassemia (1)
Silymarin (2) · Lactose (1) · milk-thistle extract (1)
Iran (1) · United States (1)
Behjat Moayedi, Professor (1) · K. Rajender Reddy, MD (1) · Michael Fried, MD (1) · Nezam Afdhal, MD (1) · Stephen A. Harrison, MD (1) · Steven H. Belle, PhD (1) · Victor Navarro, MD (1)